The VCH Travel Clinic is completely out of Yellow Fever Vaccine as of February 24, 2020. There is currently only one licensed marketer of the vaccine in Canada. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the immunization of U.S. travelers by mid-2017. Travel clinics may be allotted a small fraction of the number of vaccines typically ordered, or in some cases, travel clinics will not have access to the yellow fever vaccine until a new supply of the vaccine is available.

CDC, the Food and Drug Administration (FDA), and Sanofi Pasteur are collaborating to ensure a continuous yellow fever vaccine supply in … Yellow fever control is based on the prevention of outbreaks, and this can only be achieved if the majority of the population is immunized.

"YF-VAX is the only yellow fever vaccine licensed … If you are traveling to a part of the world for which Yellow Fever is required or recommended, you should schedule an appointment for a Travel Consult at the Travel Clinic as soon as possible. Sanofi has identified sites throughout the United States to include in the program so patients can have continued access to yellow fever vaccine. For most travelers, a single dose of yellow fever vaccine provides long-lasting protection and a booster dose of the vaccine is not needed.

Vaccination is the best protection against this virus. Mild symptoms of yellow fever include: fever, nausea, vomiting, headache, abdominal and muscle pains. Practitioners should consider scheduling several patients for immunization simultaneously to conserve use of YF-Vax 5-dose vials.

A two-pronged strategy is used to achieve this goal. Yellow Fever Vaccine: Company Name: SANOFI PASTEUR LIMITED: Market Status: MARKETED: Active Ingredient(s) Yellow fever virus strain 17D-204: Strength(s) 109648PFU: Dosage form(s) POWDER FOR SOLUTION: Route of administration: INTRAMUSCULAR: Packaging size: 5 x 0.5 mL dose vials with diluent / 5 fioles de 1 dose de 0,5 mL avec diluant: ATC code: J07BL: ATC description: VIRAL VACCINES… The EAP allows the importation and use of STAMARIL vaccine in place of YF-VAX vaccine to fulfill U.S. yellow fever immunization demand until production of YF-VAX vaccine resumes. [2] Practitioners should consider scheduling several patients for immunization simultaneously to conserve use of YF-Vax 5-dose vials.

What Is Yellow Fever? Yellow fever vaccine shortages pose a challenge. According to the CDC, yellow fever is a mosquito-borne viral disease present in Africa and South America.The infection can range from mild to severe. Periodic, temporary yellow fever vaccine shortages have occurred in the United States as a result of manufacturing problems, including a manufacturing complication in 2016 that resulted in the loss of a large number of U.S.-licensed yellow fever vaccine doses.

Global Shortage. Our goal is to support continued access to yellow fever vaccination for travelers to international destinations where yellow fever vaccine is required or recommended. Angola is battling a yellow fever outbreak amid a global shortage of the vaccine. Yellow fever vaccine is safe and effective and provide immunity within one week in 95% of those vaccinated. Experts agreed with this proposal at a meeting convened by WHO to consider potential shortages in yellow fever vaccine due to the outbreak in Angola and Democratic Republic of theCongo. Note 1: Since 2017, large outbreaks of hepatitis A among adults have been occurring in a number of US cities and states, resulting in increased demand for vaccine. Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. Total Depletion of US Licensed Supply of Yellow Fever in USA. They are reassessing the timing of YF-Vax return to supply and expect to provide an update by the second quarter of 2020.

The yellow fever vaccine given as one fifth of the regular dose could be used to control an outbreak in case of vaccine shortages. Experts agreed with this proposal at a meeting convened by WHO to consider potential shortages in yellow fever vaccine due to the outbreak in Angola and Democratic Republic of theCongo. Vaccination is the single most important measure for preventing yellow fever.

Sanofi Pasteur, the manufacturer of the only yellow fever vaccine (YF-Vax) licensed in the United States, has announced that YF-Vax for civilian use is now totally unavailable from the manufacturer until mid-2018 because of delays in the production process.

*See a list of Airport Vaccination Centers offering Yellow Fever vaccine Fractional Doses. Yellow fever vaccine is available at designated vaccination centers. Locations of centers are available from your local health department or on CDC’s Travelers’ Health Yellow Fever Vaccination Clinics page. Current Vaccine Shortages and Delays.

[2]